TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Child Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Parent Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Child Emotional Distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ELISPOT response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline of the total score of Knowledge and Attitudes Survey Regarding Pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cotinine clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Change in Pouchitis Disease Activity Index (PDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal function measured by estimated glomerular filtration rate (GFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: successful cardiopulmonary resuscitation (CPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: in-hospital intracranial hemorrhage (ICH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: in-hospital major bleedings (other than ICH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Safety and tolerability of RNA-144101
Endpoint domain: Adverse events/effects
Primary endpoint: Subjective Appeal
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive Affect Negative Affect Schedule
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Questionnaire of Vaping Urges
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Oxford Hip Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of Postoperative Nausea and Vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of Berger & Bowman Dermal Response Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Minimum stent area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ADHD-RS-IV Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Amount of Protein Received
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total Amount of Energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of perioperative maternal complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of women developing adverse outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Sleep Bruxism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Monthly Migraine Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Syncope
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Return to urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Food likes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived visual dependence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postural visual dependence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: A history of falls
Endpoint domain: Adverse events/effects
Primary endpoint: Device usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cumulative Incidence Rate (CIR)
Endpoint domain: Mortality/survival
Primary endpoint: Inspiratory Capacity at Rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Endurance Time During Constant Work Rate Cycle Ergometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hamilton Depression Scale (HAM-D) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wrist bone cartilage thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Infection or reactivation of varicella zoster virus (VZV)
Endpoint domain: Adverse events/effects
Primary endpoint: Suppression of testosterone to chemical castration levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of patients reporting dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients who experience a treatment-related adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients requiring interruptions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients who discontinued treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients requiring a dose reduction
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of acceptance of molecular tumor board recommendations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Benefit from PMMTB recommended treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression and anxiety assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Amino acid profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Subjects Reporting Solicited Local and Systemic Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentages of Subjects With Diphtheria and Tetanus Antitoxin Units >= 0.1/mL After Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hemoglobin (Hb) values comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PET Amyloid Burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PET Tau Deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Functional decline - Katz (ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of life - SF 36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cognitive decline - MMSE 30
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: post operative inflammatory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Brain injury assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in immunologic, structural and hyperproliferative state of the skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Evidence of cellular atypia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of influenza
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of subjects meeting ACR 20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients who required orotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Stay in an intensive care unit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percentage of females seeking contraception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Oral Dimethyl Fumarate (DMF) Persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain experienced during first trimester abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety experienced during first trimester abortion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Multi-Directional Reach Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Quality of Life (PedsQL) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total Number of Medications
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in PANSS negative subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Consumption of Fruits and Vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the Consumption of Dairy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the Consumption of Processed Foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the Consumption of Sugary Drinks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the Consumption of Natural Water
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Levels of Stress for Caregivers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of lunchboxes that contain a sugary snack post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Proportion of lunchboxes that contain a chilled sugary dessert post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Alcohol use, heavy drinking quantity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol use, drinks per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual aggression perpetration
Endpoint domain: Adverse events/effects
Primary endpoint: Agreement between clinical diagnoses and BAFPA results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Bloodstream infection due to central venous catheter
Endpoint domain: Adverse events/effects
Primary endpoint: Central venous catheter exit site infection
Endpoint domain: Adverse events/effects
Primary endpoint: Inadequate hemodialysis blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adenoviral eradication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Clinical resolution of the infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: NCF improvement by Alzheimer Disease Assessment Scale-Cognitive subscale (ADAS-Cog)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NCF improvement by Mini-Mental State Examination (MMSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NCF improvement by verbal fluency test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient-reported disability 30 days after surgery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of in-bed leg cycling research sessions terminated
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Child nutritional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hepatitis C seroconversion
Endpoint domain: Adverse events/effects
Primary endpoint: Systemic infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Hepatic failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Sustained Virologic Response 12 Weeks After Completing Study Therapy (SVR12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With ≥1 Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Hourly Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability assessment
Endpoint domain: Adverse events/effects
Primary endpoint: Liver transaminase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrimination of patients using multimodal MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in level of spasticity of upper limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Lateral Mitral Annular Myocardial Relaxation Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence Rate of Maternal Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence Rate of Infant Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Patients with deliverable text messages
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of phone calls where interviewer is adherent to MI
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in level of hemoglobin (g/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants with positive Tzanck smear
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percent time spent in target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of care measured by variation of timelines
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Difference in Commensal bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serial plasmatic uric acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Participants Retained in Study at 3 Months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Retention at 12 Months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Daily Total Alcohol Consumption From Baseline at 3 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Alcohol Consumption at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent days abstinent from illicit drugs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in mitochondria function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in cardiolipin species
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of mitochondrial biology in blood and skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital Re-admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Occurrence Rate of Bone metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: World Health Organization Quality of Life-Short version (WHOQOL-BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Gantenerumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time Zero (Predose) to Extrapolated Infinite Time (AUC 0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean calcium intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Heart failure clinical composite response endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Liver Fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: S-CTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: S-P1NP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Global work index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global constructed work
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission According to DAS28-CRP at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Remission According to DAS28-CRP at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Remission According to DAS28-CRP at Week 104
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Orthostatic Hypotension at Discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Mean Sitting Diastolic Blood Pressure (msDBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in peripheral vascular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: 3D soft-tissue changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from time 0 to the last observed non-zero concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Levels of CD8+ T-cell Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate and extent of absorption of oral codeine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratios of the observed concentration of each metabolite to the observed concentration of parent drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Formation and clearances of the metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Total Volume of Fluid Administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor or Sensory Response(s) During Lead Placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient Assessment of Constipation Quality-of-Life (PAC-QoL) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of Participants With Positive CD3+ T Cell Immune Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: changes in metabolic syndrome parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Minimal Disease Activity status achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PsA development (Fulfilment of the CASPAR criteria)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic ability determined by image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post FESS changes in the Lund-Kennedy Endoscopic Score (LKES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post FESS changes in the Peri-Operative Sinus Endoscopy (POSE) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post FESS changes in the validated Sino-Nasal Outcome Test 22 (SNOT-22) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cardiovascular outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vaccine Efficacy
Endpoint domain: Mortality/survival
Primary endpoint: Postnatal clinical neurologic or sonographic brain abnormality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in the number of unsecured firearms stored in the household
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of LDLR Gene Mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Major Adverse Cardiovascular Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of Major Adverse Limb Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Urinary anthocyanin and ellagitannin metabolite excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Observed dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Distribution volume ratio (DVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients screened and considered eligible to take part in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in affective valence (pleasure-displeasure)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in perceived exertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in enjoyment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Subjective appetite (hunger)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subjective appetite (fullness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Vestibular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes